Home  |  Contact

Cellosaurus DF15 (CVCL_Y429)

[Text version]
Cell line name DF15
Accession CVCL_Y429
Resource Identification Initiative To cite this cell line use: DF15 (RRID:CVCL_Y429)
Disease Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_Y430 (DF15R)
Category Cancer cell line
Publications

Patent=US20070027175
Shaughnessy J.D. Jr., Tian E.-M.
Antineoplastic activities of ellipticine and its derivatives.
Patent number US20070027175, 01-Feb-2007

PubMed=22552008; DOI=10.1038/leu.2012.119
Lopez-Girona A., Mendy D., Ito T., Miller K., Gandhi A.K., Kang J., Karasawa S., Carmel G., Jackson P., Abbasian M., Mahmoudi A., Cathers B., Rychak E., Gaidarova S., Chen R., Schafer P.H., Handa H., Daniel T.O., Evans J.F., Chopra R.
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.
Leukemia 26:2326-2335(2012)

Cross-references
Encyclopedic resources Wikidata; Q54831023
Entry history
Entry creation07-Nov-2014
Last entry update21-Mar-2023
Version number4